Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 40,000 shares at $8.52 ($341K) on 2016-05-20, disclosed to the SEC on 2016-05-23.
Open-market sale of $341k KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| KPTI | SELL | 2018-07-23 | $4.8M | — | Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |